Concepedia

Chinami Masuda

CM

3

Publications

133

Citations

3

H-Index

2017

Active since

Affiliations

Kumamoto University(Current)

Chinami Masuda is an author at Kumamoto University specializing in tumor biology, cancer therapeutics, and oncology.

ORCID

Top concepts

Publications per year

2017–2019

3

Publications

3

Bevacizumab counteracts VEGF-dependent resistance to erlotinib in an EGFR-mutated NSCLC xenograft model

Chinami Masuda, Mieko Yanagisawa, Keigo Yorozu et al. · International Journal of Oncology · 2017 · 82 citations · Full text

, , +16

Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model

Chinami Masuda, Masamichi Sugimoto, Daiko Wakita et al. · Clinical & Experimental Metastasis · 2019 · 35 citations · Full text

MALDI mass spectrometry imaging of erlotinib administered in combination with bevacizumab in xenograft mice bearing B901L, EGFR-mutated NSCLC cells

Masanobu Nishidate, Kaname Yamamoto, Chinami Masuda et al. · Scientific Reports · 2017 · 16 citations · Full text

, , +15

Rows per page

1–3 of 3